SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (16013)8/30/2002 7:26:04 AM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
And I thought i was the only one that cared about bpi. So,
cacaito you know my level of interest in bpi, let me hear yout current thinking on its potential. Thanks
fwiw, i think xoma is fustrated with baxter, at the minimum. If xona was smart they would play their non-bpi21 >bpi entities, but dropping a mycoprex is the OPPOSITE strategy. When will they ever be what they can be?



To: Cacaito who wrote (16013)9/8/2002 11:20:11 PM
From: Bluegreen  Respond to of 17367
 
Cacaito or Bob, please read this and then tell me what effect if any it would have on someone given blood in hemo trauma trial. Were the people in the trial only given RBC's or whole blood and if given only RBC's would any BPI be in with them from separation process???
ncbi.nlm.nih.gov



To: Cacaito who wrote (16013)9/10/2002 11:34:55 AM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Cacaito, can you explain the latest BSTE, XOMA situation????


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News